Plazomicin sulfate

N/A

Report date: 2026/06/09 20:00:18
NMEQIDP

Base Information

Drug NamePlazomicin sulfate
Drug Alias Nameplazomicinum普拉米星普拉左米星plazomicine普拉佐米星 +[11] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of ActionProtein biosynthesis inhibitors30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsHospital-acquired pneumoniaKidney Failure, ChronicRenal Insufficiency +[10] 
Global Approved IndicationsPyelonephritisUrinary Tract Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/06/25
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCipla Usa IncAchaogen IncXuanzhu (Shijiazhuang) Biotechnology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[4] 
Inactive IndicationsKidney Failure, ChronicRenal InsufficiencyPneumonia, Ventilator-Associated +[6] 

Other Information

ATC CodeJ01GB14
Related LinksWikipediaDrugBankKEGG